Pharma major Ranbaxy Laboratories has set aside Rs 257.4 crore (Rs 2.57 billion) towards the financial impact of a US ban on import of products made at its plant at Toansa.
Polling will be held in all 13 seats in Punjab and an equal number of seats in Uttar Pradesh, nine in West Bengal, eight seats each in Bihar and Madhya Pradesh, four in Himachal Pradesh, three in Jharkhand and the lone seat Chandigarh.
While the US health regulator did not specify details for issuing the alert, it said 'detention without physical examination may be appropriate when an FDA inspection has revealed that a firm is not operating in conformity with current good manufacturing practices'.
Last year, Ranbaxy had paid around $4,20,000 to the US state of Idaho as part of a $500-million settlement that the drug firm had signed with US authorities.
4 Ranbaxy facilities in India have been barred from exporting to US.
Shops, schools and other commercial establishments were closed in parts of Bihar, Rajasthan, Madhya Pradesh, Uttar Pradesh and Punjab but the shutdown call by anti-reservation bodies had little impact elsewhere in the country.
The Supreme Court on Monday posed some tough questions to a lawyer, asking him to substantiate his "unfounded allegations" in a PIL that Indian pharma major Ranbaxy Laboratories Ltd was allegedly manufacturing and selling adulterated medicines.
Company is among the few companies in the sector getting pulled up by FDA for violations at its factories in India.
In 2014, Sun Pharma agreed to buy Ranbaxy -- which was then controlled by Daiichi.
Farmers said a big reason for the anger was the sudden stopping of wheat procurement by the state government in some places, which had caused the prices to dip below the minimum support price.
Taking exception to Health Minister Harsh Vardhan not mentioning the death of healthcare workers due to Covid-19 in his statement in Parliament, the Indian Medical Association has published a list of 382 doctors who died due to the viral disease and demanded that they be treated as "martyrs".
If RBI has to replace the entire stock of Rs 1,000 and Rs 500 notes with Rs 100 ones, the cost would be more than Rs 10,000 crore.
The NIA's chargesheet in the 2006 Malegaon blasts mocks the investigation conducted by the Maharashtra Anti-Terrorism Squad into the matter, reports Vicky Nanjappa
Brokerages have cut the company's FY16 earnings estimates between 16% and 29% with target prices too coming down to the Rs 700-800 band
In May this year, Ranbaxy had pleaded guilty to 'felony charges' for violating manufacturing norms and agreed to pay $500 million penalty to US authorities.
While it took the Congress nearly a half century to earn the hatred of other political outfits, the BJP appears set to reach there in around six years, says Arun Bhatnagar, former secretary to the GoI.
A source said the competition watchdog would by next month suggest 'structural remedies' that included selling key drug segments as conditions for clearing the country's largest pharmaceutical industry merger.
A day after getting a show-cause notice from the Indian regulator, senior executives from Ranbaxy Laboratories approached the drug controller's office on Tuesday afternoon, it was learnt.
The PIL , filed by advocate M L Sharma, sought action against Ranbaxy for allegedly supplying substandard and adulterated drugs
The Lok Sabha election will be held in 7 phases, beginning on April 11, 2019 and ending on May 19, 2019.
In 2013, Daiichi had launched the arbitration proceedings in Singapore.
Sun Pharma expects synergy benefits by next fiscal.
Sun Pharma would have to do a lot of work to get USFDA to revoke the ban on Ranbaxy facilities but it has not put any time-frame for this, company ChairmanIsrael Makov said.
Pipliyamandi becomes the epicentre of the current farmers' agitation across the country, demanding better price for their produce and loan waiver and a political hot-potato for all.
Import alert on Ranbaxy's Mohali unit; Strides' injectible arm gets warning letter
The recall is the latest in a series of problems to hit Ranbaxy, which has had all its India factories stopped from sending drugs and ingredients to the United States.
The government on Monday countered the Congress charges of snooping on Rahul Gandhi saying it was making a "mountain out of what is not even a molehill" as information collection was part of a transparent security profiling used on 526 VIPs, including Sonia Gandhi and former prime ministers.
The VHP will focus on non-religious topics and give the Ram temple a miss at the three-day Vaicharik Kumbh, to be attended by Prime Minister Narendra Modi. Shashikant Trivedi reports.
Last month, the US Food and Drugs Administration had placed Wockhardt's facilities in Waluj near Aurangabad on import alert, barring supply of various products from these facilities to the US.
The NIA has found nothing to suggest that Sadhvi Pragya Singh Thakur and 3 others were involved in Malegaon and Samjhauta blasts accused Sunil Joshi's murder, reports Vicky Nanjappa.
This classification of districts is to be followed by states and union terrotories till a week post May 3, when the second phase of lockdown will end, for containment operations.
James Wilson tracks down discrepancies in the much-hailed demonetisation policy and the subsequent statements of the government and the Reserve Bank of India.
Consultants are working with various teams on manufacturing, R&D, etc, to assess per-month productivity of each department.
FDA allows Teva to launch Nexium generic; Cipla, which supplies formulation, to gain
The Halol facility is important for the company as it accounts for 10 per cent of Sun Pharma's sales.
In a surprise announcement in April, Sun and Ranbaxy -- at that time owned by Japan's Daiichi -- declared an all-stock deal to create India's largest and world's fifth-largest drugmaker in an over $4 billion deal.
'Most of the agitations are staged by the Opposition to disturb the peace of the state.'
In the first of a four-part series, Business Standard takes a look at how a mint in Salboni, West Bengal, is working overtime to print currency notes.
The country's drug companies have attracted the highest number of enforcements from the American drug regulator in 2013, a year that has seen the US Food and Drug Administration turning stricter to ensure compliance levels and quality of medicines.
'My grandmother taking me to the jamatkhana was like a different world.' 'Like I had a key to a door which no one else seemed to have.' 'She doesn't take me anymore because she says I'm an embarrassment!'
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances